Aphea.Bio

1. 26 Jun 2017
   Series AVenture / equity1 sourceEUR 7.7M⌄

   Reported amount EUR 7,700,000

   Investor-issued announcement separates EUR 7.7m equity from EUR 1.3m non-dilutive capital; headline EUR 9m is not the equity round.

   • ↗ Aphea.Bio Raises 9 Million Euros in Funding prnewswire.co.uk

   Deal record ↗

   InvestorsV-Bio VenturesPMVAgri Investment FundVIVES Louvain Technology FundQbic IIGemma Frisius FundGroup De CeusterVIB
2. 20 Nov 2020
   Series b first closeVenture / equity1 sourceEUR 14M⌄

   Reported amount EUR 14,000,000

   Investor release datelined November 20 confirms EUR 14m first Series B close.

   • ↗ Aphea.Bio lève 14 millions d'euros en Série B vivesfund.com

   Deal record ↗

   InvestorsAVAstanor VenturesV-Bio VenturesAgri Investment FundPMVVives FundVIBQbic IIGemma Frisius Fund
3. 14 Apr 2021
   Series b extensionVenture / equity1 sourceEUR 4M⌄

   Reported amount EUR 4,000,000

   ECBF investment increases Series B from EUR 14m to EUR 18m; incremental EUR 4m derived from the two disclosed totals.

   • ↗ European Circular Bioeconomy Fund expands Aphea.Bio Series B funding round to EUR 18 million ecbf.vc

   Deal record ↗

   InvestorsEuropean Circular Bioeconomy Fund
4. 11 Jul 2023
   Series CVenture / equity1 sourceEUR 70M⌄

   Reported amount EUR 70,000,000

   Company announces successful EUR 70m Series C closing.

   • ↗ Aphea.Bio secures €70 million Series C Funding aphea.bio

   Deal record ↗

   InvestorsAVAstanor VenturesSFPIMInnovation IndustriesKorys InvestmentsBill & Melinda Gates FoundationBNP Paribas FortisECBFAgri Investment Fund

Recorded history so far. Original currencies are preserved; amounts in different currencies are not added together. Debt, grants, acquisitions and listings are separate event types. Undated events appear last.